RNA-seq unravels distinct expression profiles of keloids and Dupuytren's disease

Bibliographic Details
Title: RNA-seq unravels distinct expression profiles of keloids and Dupuytren's disease
Authors: Marcus Stocks, Annika S. Walter, Elif Akova, Gerd Gauglitz, Attila Aszodi, Wolfgang Boecker, Maximilian M. Saller, Elias Volkmer
Source: Heliyon, Vol 10, Iss 1, Pp e23681- (2024)
Publisher Information: Elsevier, 2024.
Publication Year: 2024
Collection: LCC:Science (General)
LCC:Social sciences (General)
Subject Terms: Science (General), Q1-390, Social sciences (General), H1-99
More Details: Keloid scars and Dupuytren's disease are two common, chronic, and incurable fibroproliferative disorders that, among other shared clinical features, may induce joint contractures. We employed bulk RNA sequencing to discern potential shared gene expression patterns and underlying pathological pathways between these two conditions. Our aim was to uncover potential molecular targets that could pave the way for novel therapeutic strategies. Differentially expressed genes (DEGs) were functionally annotated using Gene Ontology (GO) terms and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways with the Database for Annotation, Visualization, and Integrated Discovery (DAVID). The protein-protein-interaction (PPI) networks were constructed by using the Search Tool for the Retrieval of Interacting Genes (STRING) and Cytoscape. The Molecular Complex Detection (MCODE) plugin was used for downstream analysis of the PPI networks. A total of 1922 DEGs were identified within Dupuytren's and keloid samples, yet no overlapping gene expression profiles were detected. Significantly enriched GO terms were related to skin development and tendon formation in keloid scars and Dupuytren's disease, respectively. The PPI network analysis revealed 10 genes and the module analysis provided six protein networks, which might play an integral part in disease development. These genes, including CDH1, ERBB2, CASP3 and RPS27A, may serve as new targets for future research to develop biomarkers and/or therapeutic agents.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2405-8440
Relation: http://www.sciencedirect.com/science/article/pii/S2405844023108899; https://doaj.org/toc/2405-8440
DOI: 10.1016/j.heliyon.2023.e23681
Access URL: https://doaj.org/article/289e4e5ab66c472bb1ad504abde03ef2
Accession Number: edsdoj.289e4e5ab66c472bb1ad504abde03ef2
Database: Directory of Open Access Journals
More Details
ISSN:24058440
DOI:10.1016/j.heliyon.2023.e23681
Published in:Heliyon
Language:English